Price Movement and Market Context
On 18 Aug 2026, CARE Ratings closed at ₹1,688.50, down 1.73% from the previous close of ₹1,718.25. The stock traded within a range of ₹1,688.50 to ₹1,749.95 during the day, remaining below its 52-week high of ₹1,836.00 but comfortably above the 52-week low of ₹1,393.95. This price behaviour reflects a consolidation phase after a period of strong gains over the past few years.
Comparatively, CARE Ratings has outperformed the Sensex over multiple time horizons. Year-to-date, the stock has gained 5.48%, while the Sensex declined by 8.79%. Over one year, CARE Ratings returned 3.52% against the Sensex’s negative 3.56%. The long-term performance is even more impressive, with a three-year return of 125.67% compared to the Sensex’s 19.30%, and a five-year return of 150.74% versus 39.32% for the benchmark. However, the ten-year return of 41.20% trails the Sensex’s 177.55%, indicating some recent relative underperformance in the longer term.
Technical Indicator Analysis
The technical landscape for CARE Ratings is mixed, with several key indicators signalling both strength and caution. The overall technical trend has shifted from bullish to mildly bullish, suggesting a tempering of upward momentum but not a reversal.
The Moving Average Convergence Divergence (MACD) indicator presents a split view: the weekly MACD remains bullish, indicating positive momentum in the short term, while the monthly MACD has turned mildly bearish, signalling potential weakening in the longer-term trend. This divergence suggests that while short-term traders may find opportunities, longer-term investors should exercise caution.
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum extremes implies the stock is neither overbought nor oversold, consistent with the consolidation phase observed in price action.
Bollinger Bands on weekly and monthly timeframes are mildly bullish, indicating that price volatility is contained within an upward bias. This supports the notion of a controlled, steady advance rather than a sharp breakout or breakdown.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Additional Technical Signals
The daily moving averages remain bullish, reinforcing short-term upward momentum. This is a positive sign for traders looking for entry points aligned with the prevailing trend. However, the Know Sure Thing (KST) indicator on both weekly and monthly charts is mildly bearish, suggesting some underlying weakness in momentum that could limit further gains.
Dow Theory assessments show no clear trend on the weekly chart and a mildly bearish stance on the monthly chart, indicating that the broader market sentiment for CARE Ratings is cautious. Meanwhile, the On-Balance Volume (OBV) indicator presents a bullish signal on the monthly timeframe, implying that volume trends support price advances over the longer term, even if short-term momentum is subdued.
Mojo Score and Grade Update
CARE Ratings currently holds a Mojo Score of 64.0, which corresponds to a Hold grade. This represents a downgrade from a Buy rating issued on 11 Aug 2026. The downgrade reflects the mixed technical signals and the recent price pullback. The company is classified as a small-cap within the capital markets sector, which typically entails higher volatility and risk compared to large-cap peers.
Investors should weigh the stock’s strong historical returns and current technical consolidation against the cautious signals from monthly momentum indicators and the recent downgrade. The Hold rating suggests a wait-and-watch approach rather than aggressive accumulation at this stage.
Holding CARE Ratings Ltd from Capital Markets? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
CARE Ratings’ technical profile suggests a stock in transition. The shift from a bullish to mildly bullish trend, combined with mixed signals from MACD, KST, and Dow Theory, indicates that momentum is moderating. The absence of RSI extremes and the mildly bullish Bollinger Bands point to a period of consolidation rather than a decisive breakout or breakdown.
Given the stock’s strong relative performance against the Sensex over the medium term, investors may consider maintaining exposure but with caution. The Hold Mojo Grade aligns with this view, signalling that while the stock is not currently a strong buy, it remains a viable holding for those with a medium-term horizon.
Traders should monitor the weekly MACD and daily moving averages for signs of renewed strength, while longer-term investors ought to watch monthly momentum indicators for confirmation of trend direction. Volume trends, as indicated by OBV, remain supportive, which is a positive factor for sustained price stability.
In summary, CARE Ratings Ltd presents a balanced risk-reward profile at present, with technical momentum showing signs of moderation but not reversal. Investors should remain vigilant for further developments in technical indicators and broader market conditions within the capital markets sector.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
